Prof Tony Costello, MD, FRACS, FRCSI (HON), MBBS
Director of Urology, The Royal Melbourne Hospital
Prof Costello is Professorial Fellow & Head Department of Urology, The Royal Melbourne Hospital, affiliated with Department of Surgery, University of Melbourne. His major interest is prostatic cancer – localised therapy and emerging treatments for advanced metastatic prostate cancer. In 1998 he completed his Doctorate in Medicine by thesis on Laser tissue interaction and application of lasers in prostatic surgery. He was the first urologist to use lasers to treat benign prostatic hyperplasia and has had international recognition in this field. Prof Costello was trained in surgery in Melbourne and then subsequently completed fellowship training at the University of Texas, MD Anderson Hospital & Cancer Centre, and the London Hospital in the University of London.
His current interest is in the development of drug treatment for metastatic prostate cancer and in clinical applications of robotics in prostate cancer surgery. He heads the largest robotic surgery program in Australia and has been invited to teach the technique of robotic prostatectomy for prostate cancer surgery at the American Association of Urological Surgery Annual General Meeting on several occasions. Prof Costello was elected to membership of the American Association of Genitourinary Surgeons in 2004. He is also an invited member of the International Advisory Board of the Cleveland Clinic Urological Department.
In 2005 he attracted grants from the Victorian Government, University of Melbourne, and the University of Queensland for $1.8 million for development of a novel biological treatment of hormonal refractory prostate cancer. This substance is now being trialled in phase I treatment for men with hormonal refractory prostate cancer.
Prof Costello has an established international urologic oncology fellowship program commencing in 1991 and there have been over 45 fellows from all parts of the world come for periods of one year and beyond to learn postgraduate urologic oncology surgery.